[go: up one dir, main page]

WO2025222373A1 - Composition pour le nettoyage et/ou le démaquillage de matières kératiniques - Google Patents

Composition pour le nettoyage et/ou le démaquillage de matières kératiniques

Info

Publication number
WO2025222373A1
WO2025222373A1 PCT/CN2024/089308 CN2024089308W WO2025222373A1 WO 2025222373 A1 WO2025222373 A1 WO 2025222373A1 CN 2024089308 W CN2024089308 W CN 2024089308W WO 2025222373 A1 WO2025222373 A1 WO 2025222373A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
sodium
composition according
glutamate
cocoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/CN2024/089308
Other languages
English (en)
Inventor
Yong Wang
Nariyoshi YOSHIOKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to PCT/CN2024/089308 priority Critical patent/WO2025222373A1/fr
Priority to FR2405387A priority patent/FR3161358A3/fr
Publication of WO2025222373A1 publication Critical patent/WO2025222373A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Definitions

  • the present invention relates to a composition, preferably for cleansing and/or removing makeups from keratin materials.
  • the present invention also relates to a non-therapeutic process for cleansing and/or removing makeups from keratin materials using said composition.
  • Cleansing the skin or removing makeups from the skin is very important for caring for the skin. It must be as efficient as possible because greasy residues, such as excess sebum, the remnants of cosmetic products used daily and make-up products, in particular waterproof products, accumulate in the skin folds, and can block the pores of the skin and result in the appearance of spots.
  • Rinsable anhydrous oils and gels have a cleansing or makeup removing action by virtue of oils present in these formulations. These oils make it possible to dissolve fatty residues and to disperse make-up pigments. These products are effective and well tolerated.
  • foaming creams, lotions, and gels have a cleansing or makeup removing action by virtue of the surfactants, which suspend the fatty residues on the face. They are effective and pleasant to use because they foam, and they are easy to remove.
  • compositions preferably for cleansing or removing makeups from keratin materials, having good foaming ability, while providing a good skin sensory, in particular, skin smoothness.
  • the present invention relates to a composition, preferably for cleansing and/or removing makeups from keratin materials, comprising:
  • composition according to the present invention provides a good foaming volume during application.
  • composition according to the present invention further provides a good skin sensory (in particular, a moisturized and smooth skin feeling) after application.
  • a good skin sensory in particular, a moisturized and smooth skin feeling
  • the composition according to the present invention is a crystalized system in the form of a paste, cream, or texturized lotion.
  • It may be used as a daily facial cleanser and/or makeup remover.
  • the composition of the present invention is a rinse-off product.
  • the composition of the present invention can provide a quick rinse-off speed.
  • a composition can be applied on the skin (i.e., face and/or body) , and then rinsed with flush water.
  • the present invention provides a non-therapeutic process for cleansing and/or removing makeups from keratin materials, in particular the skin, comprising the application to the keratin materials, in particular the skin, of the composition according to the present invention, and rinsing off said composition after an optional period of time.
  • keratin material is intended to cover human skin, mucous membranes such as the lips. Facial skin is most particularly considered according to the present invention.
  • composition of the present invention comprises:
  • composition according to the present invention comprises at least one glycolipid.
  • glycolipid is understood as meaning a compound formed from a lipid to which are attached one or more sugar compounds.
  • glycolipids can work as mild surfactants, so as to care skin, and deliver a not dry and smooth skin finish. And it also works as a foaming booster.
  • the glycolipid is selected from rhamnolipids, glucolipids, sophorolipids, trehalolipids, cellobioselipids, and mixtures thereof.
  • the glycolipid is selected from rhamnolipids, glucolipids, trehalolipids, and mixtures thereof.
  • the glycolipid is selected from rhamnolipids.
  • the (a) glycolipids may be glucolipids, which contain a glucose moiety and can be represented by the general formula (I) :
  • -R 1 represents a hydrogen atom or a cation
  • -p denotes an integer ranging from 1 to 4,
  • -q denotes an integer ranging from 4 to 10, preferably equal to 6.
  • the glucolipids can be produced by the bacterium Alcaligenes sp. MM1.
  • glucolipids are recovered from the fermentation broth by solvent extraction using diethyl ether or a dichloromethane: methanol or chloroform: methanol mixture.
  • glycolipids may be sophorolipids, which contain a sophorose moiety and can be represented by the general formula (II) :
  • R 3 and R 4 individually represent a hydrogen atom or an acetyl group
  • -R 5 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 1 to 9 carbon atoms, preferably methyl,
  • -R 6 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 1 to 19 carbon atoms
  • the total number of carbon atoms in the groups R 5 and R 6 does not exceed 20 and is preferably from 14 to 18.
  • Sophorolipids may be incorporated into the composition according to the present invention either in the form of an open-chain free acid, where R 7 represents a hydrogen atom and R 8 represents a hydroxy group OH, or in its lactone form, where a lactone ring is formed between R 7 and R 8 , as indicated by formula (III) :
  • R 3 -R 3 , R 4 , R 5 and R 6 are as defined above,
  • R 3 and R 4 represents an acetyl group.
  • the sophorolipids can be produced by yeast cells, for example, Torulopsis apicola and Torulopsis bombicola cells.
  • the fermentation process generally uses sugars and alkanes as substrates.
  • sophorolipid for example the product sold under the name Sopholiance S by Givaudan and the product sold under the name BioToLife by BASF.
  • glycolipids may be trehalolipids, which contain a trehalose moiety and can be represented by the general formula (IV) :
  • R 10 and R 11 individually represent a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 5 to 13 carbon atoms.
  • the trehalolipids can be produced by bacterial fermentation using the marine bacterium Arthrobacter sp. Ek 1 or the freshwater bacterium Rhodococcus erythropolis.
  • Appropriate fermentation methods are provided by Ishigami et al. (1987) , J. Jpn. Oil Chem. Soc., 36, 847-851, Schultz et al. (1991) , Z. Naturforsch., 46C, 197-203, and Passeri et al. (1991) , Z. Naturforsch., 46C, 204-209.
  • the glycolipids may be cellobiose lipids, which contain a cellobiose moiety and can be represented by the general formula (V) :
  • -R 1 represents a hydrogen atom or a cation
  • R 12 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon radical having from 9 to 15 carbon atoms, preferably 13 carbon atoms,
  • -R 13 represents a hydrogen atom or an acetyl group
  • -R 14 represents a saturated or unsaturated, hydroxylated or non-hydroxylated hydrocarbon group having from 4 to 16 carbon atoms.
  • the cellobiose lipids can be produced by cells of fungi of the genus Ustilago. Appropriate fermentation processes are provided by Frautz, Lang and Wagner (1986) , Biotech. Letts., 8, 757-762.
  • the glycolipids may be rhamnolipids.
  • composition according to the present invention preferably comprises one or more rhamnolipids.
  • Rhamnolipids are glycolipids produced by various bacterial species. They consist of one rhamnose moiety (mono-rhamnolipid) or of two rhamnose moieties (di-rhamnolipid) linked by a glycosidic bond to one, two or three chains of ⁇ -hydroxylated fatty acids linked to one another by an ester bond.
  • -m denotes an integer equal to 2, 1 or 0,
  • -n denotes an integer equal to 1 or 0,
  • R 1 and R 2 each independently represent identical or different hydrocarbon groups having from 2 to 24 carbon atoms, preferably from 5 to 13 carbon atoms, that are branched or unbranched, substituted or unsubstituted, in particular hydroxy-substituted, and saturated or unsaturated, preferably a singly, doubly or triply unsaturated hydrocarbon group.
  • composition according to the invention preferably comprises at least one di-rhamnolipid.
  • composition according to the present invention preferably comprises at least one di-rhamnolipid of formula (VI) in which:
  • -m denotes an integer equal to 2, 1 or 0;
  • -n denotes an integer equal to 1
  • R 1 and R 2 each independently represent identical or different hydrocarbon groups having from 2 to 24 carbon atoms, preferably from 5 to 13 carbon atoms, that are branched or unbranched, substituted or unsubstituted, in particular hydroxy-substituted, and saturated or unsaturated, preferably a singly, doubly or triply unsaturated hydrocarbon group and also the salts thereof, solvates thereof and optical isomers thereof.
  • the glycosidic bond between the two rhamnose fragments may be in the alpha or beta configuration and is preferably in the alpha configuration.
  • the salts of the di-rhamnolipids of formula (VI) are more particularly the carboxylate salts thereof with an organic or inorganic cation and especially with a cation selected from sodium, potassium, calcium and ammonium.
  • the solvated forms of the di-rhamnolipids of formula (VI) are more particularly those solvated with one or more molecules of water or of organic solvents, for example a hydrate or a solvate of a linear or branched alcohol, such as ethanol or isopropanol, the optically active carbon atoms of the fatty acids preferably being in the form of the R enantiomers, and
  • alkyl radical denotes a saturated, linear or branched aliphatic group; for example, a C 1 -C 20 alkyl group having a linear or branched hydrocarbon chain of 1 to 20 carbon atoms, more particularly a methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl or eicosyl.
  • composition according to the present invention preferably comprises at least one di-rhamnolipid of formula (VI) in which:
  • -m denotes an integer equal to 2, 1 or 0;
  • -n denotes an integer equal to 1
  • R 1 and R 2 which are identical or different, are selected from pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals and radicals of formula- (CH 2 ) o CH 3 , with o denoting an integer ranging from 1 to 23, in particular from 3 to 15 and more particularly from 4 to 12.
  • the composition according to the invention comprises at least one di-rhamnolipid of general formula (VI) in which m is equal to 1.
  • the composition according to the invention comprises a mixture of at least two, preferably at least three, di-rhamnolipids of general formula (VI) in which m is preferably equal to 1.
  • the composition according to the invention comprises a mixture comprising at least one mono-rhamnolipid.
  • composition according to the invention comprises at least one di-rhamnolipid of the following formula (VII) :
  • -m denotes an integer equal to 2, 1 or 0; preferably, m is equal to 1,
  • -n denotes an integer equal to 1
  • -R 1 is a- (CH 2 ) p -CH 3 radical, with p being an integer varying from 1 to 23, preferably from 4 to 12,
  • -R 2 is a- (CH 2 ) q -CH 3 radical, with q being an integer varying from 1 to 23, preferably from 4 to 12,
  • di-rhamnolipids of formula (VII) that may be suitable for the invention, mention may be made in particular of the compounds of formula di-RL-CXCY, such as are defined in Table A below.
  • di-RL-CXCY is an alternative way of writing in order to represent a di-rhamnolipid (di-RL) functionalized by two radicals R 1 and R 2 respectively represented by the symbols CX and CY, the integers X and Y being respectively equal to p+4 and q+4.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1, also referred to as di-RL-C10C10, or one of the salts, solvates and optical isomers thereof.
  • VI di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1, also referred to as di-RL-C10C10, or one of the salts, solvates and optical isomers thereof.
  • the di-rhamnolipid of formula (VII) in which p and q are identical and equal to 6 and m is equal to 1 is present in the composition according to the invention in a proportion of at least 50%by weight and preferably of from 51%to 85%by weight, relative to the total weight of rhamnolipids.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula (VII) in which m is equal to 1, p is equal to 6 and q is equal to 8.
  • the composition according to the invention comprises at least one di-rhamnolipid of formula (VI) in which n and m are equal to 1, R 1 represents a- (CH 2 ) o CH 3 radical, with o being an integer varying from 4 to 12, and R 2 is selected from the pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals; preferably, R 1 represents a- (CH 2 ) 6 CH 3 radical and R 2 a nonenyl radical.
  • formula (VI) in which n and m are equal to 1
  • R 1 represents a- (CH 2 ) o CH 3 radical, with o being an integer varying from 4 to 12
  • R 2 is selected from the pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undeceny
  • composition according to the present invention comprises a mixture of at least two, in particular at least three, di-rhamnolipids of formula (VI) or of formula (VII) selected from:
  • R 1 represents a- (CH 2 ) o CH 3 radical, with o being an integer varying from 4 to 12
  • R 2 is selected from the pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl and tridecenyl radicals; preferably, R 1 represents a- (CH 2 ) 6 CH 3 radical and R 2 a nonenyl radical.
  • composition according to the present invention comprises a mixture of at least two, in particular at least three, di-rhamnolipids of formula (VI) or of formula (VII) selected from:
  • rhamnolipids are customarily prepared by processes known to those skilled in the art starting from bacterial producers, such as Pseudomonas.
  • Use may be made, as rhamnolipid, of the one sold under the name ONE by Evonik (INCI name: glycolipids) .
  • the glycolipid is present in the composition according to the present invention in an amount ranging from 0.03 wt. %to 15 wt. %, preferably from 0.1 wt. %to 10 wt. %, more preferably from 0.3 wt. %to 5 wt. %, even more preferably from 0.5 wt. %to 3 wt. %, most preferably from 0.8 wt. %to 2.5 wt. %, relative to the total weight of the composition.
  • composition according to the present invention comprises at least 2 wt. %of at least one amino acid surfactant, relative to the total weight of the composition.
  • the amino acid surfactant is selected from (C8-C28) acyl-amino surfactants.
  • amino acid surfactant is represented by the formula (A) :
  • Z represents a saturated or unsaturated, linear or branched hydrocarbon group having 7 to 21 carbon atoms
  • X is hydrogen or methyl group
  • n 0 or 1
  • Y is selected from hydrogen, -CH 3 , -CH (CH 3 ) 2 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -CH 2 C 6 H 5 , -CH 2 C 2 H 4 OH, -CH 2 OH, -CH (OH) CH 3 , - (CH 2 ) 4 NH 2 , - (CH 2 ) 3 NHCH (NH 2 ) 2 , -CH 2 C (O) O - M + , - (CH 2 ) 2 C (O) OH, - (CH 2 ) 2 C (O) O - M + , and
  • M is a salt-forming cation wherein C (O) O is the counter-anion, preferably selected from sodium, potassium, ammonium, triethanolamine and mixture thereof.
  • Z represents a linear or branched C 8 -C 22 alkyl or alkenyl group
  • X is a hydrogen or methyl group
  • n 0,
  • Y is selected from hydrogen, - (CH 2 ) 2 C (O) OH, - (CH 2 ) 2 C (O) O - M + , and
  • M is a salt-forming cation wherein C (O) O is the counter-anion, preferably selected from sodium, potassium, ammonium, triethanolamine and mixture thereof.
  • amino acid surfactants include salt of alanine, arginine, aspartic acid, glutamic acid, glycine, isoleucine, leucine, lysine, phenylalanine, serine, tyrosine, valine, sarcosine, and any mixture thereof.
  • acylsarcosinates for instance the sodium lauroyl sarcosinate sold under the name Sarkosyl NL by the company Ciba or sold under the name Oramix L by the company SEPPIC, the sodium myristoyl sarcosinate sold under the name Nikkol Sarcosinate by the company Nikkol or the sodium palmitoyl sarcosinate sold under the name Nikkol Sarcosinate by the company Nikkol; alaninates, for instance the sodium N-lauroyl-N-methylamidopropionate sold under the name Sodium Nikkol Alaninate LN by the company Nikkol or sold under the name Alanone by the company Kawaken, and the N-lauroyl-N-methylalanine triethanolamine sold under the name Alanone by the company Kawaken; N-acylglutamates, for instance the triethanolamine monococoylglutamate sold under the name Acylsarcosinate sold under the name Acylsarcosinate sold under
  • the amino acid surfactant is selected from sodium lauroyl sarcosinate, sodium cocoyl glycinate, sodium lauroyl glutamate, sodium cocoyl glutamate, sodium stearoyl glycinate, sodium stearoyl glutamate, disodium cocoyl glycinate, disodium cocoyl glutamate, potassium cocoyl glycinate, TEA-cocoyl glutamate, and a mixture thereof.
  • the amino acid surfactant is present in the composition according to the present invention in an amount ranging from 2 wt. %to 40 wt. %, preferably 2.5 wt. %to 30 wt. %, more preferably from 3 wt. %to 25 wt. %, even more preferably from 4 wt. %to 20 wt. %, most preferably from 5 wt. %to 18 wt. %, relative to the total weight of the composition.
  • composition according to the present invention comprises at least one (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate.
  • the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate comprises from 1 to 50 alkylene oxide units, preferably ethylene oxide units.
  • the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is represented by the following formula (B) :
  • n designates an integer ranging from 9 to 27, preferably from 9 to 21, more preferably from 11 to 17;
  • n designates an integer varying from 1 to 50, preferably from 1 to 25, more preferably from 1 to 10;
  • M and M' designate, independently of each other, a hydrogen atom, an alkali metal or alkali earth metal, an ammonium group or a cation derived from an amine.
  • m designates an integer ranging from 1 to 8, even more preferably from 1 to 6.
  • the sulfosuccinates are in the form of salt, they can be selected from alkali metal salts such as sodium or potassium salt and preferably sodium, ammonium salts, amine salts and in particular amino alcohols, alkaline earth metal salts such as magnesium salt. In this case, one or the other of the sulfonate functions, or both, can be found in the form of salt.
  • alkali metal salts such as sodium or potassium salt and preferably sodium, ammonium salts, amine salts and in particular amino alcohols, alkaline earth metal salts such as magnesium salt.
  • one or the other of the sulfonate functions, or both, can be found in the form of salt.
  • the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is in the form of salt.
  • the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is selected from alkali metal salts, and more preferably sodium salt. Even more preferably, the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is selected from di-salts of sodium.
  • the composition comprises disodium laureth sulfosuccinate. More preferably, the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is disodium laureth sulfosuccinate.
  • the (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate is present in the composition according to the present invention in an amount ranging from 0.03 wt. %to 10 wt. %, preferably from 0.1 wt. %to 8 wt. %, more preferably from 0.3 wt. %to 5 wt. %, even more preferably from 0.5 wt. %to 3 wt. %, most preferably from 0.8 wt. %to 2.5 wt. %, relative to the total weight of the composition.
  • composition of the present invention further comprises water.
  • water is present in the composition of the present invention in an amount ranging from 35 wt. %to 95 wt. %, preferably from 40 wt. %to 80 wt. %, more preferably from 45 wt. %to 60 wt. %, relative to the total weight of the composition.
  • composition according to the present invention is free of oil.
  • oil refers to a fatty substance that is liquid at ambient temperature (25°C) and atmospheric pressure (760 mmHg, i.e., 1.013*10 5 Pa) .
  • free of oil indicates that the amount of oil in the composition of the present invention is less than 2 wt. %, preferably less than 1 wt. %, even more preferably less than 0.5 wt. %, relative to the total weight of the composition of the present invention.
  • composition according to the present invention may comprises one or more additional ingredients, selected from those conventionally used in skincare cleansers.
  • composition in accordance with the present invention may comprise, for example, one or more of the following additives: pH adjusting agents (e.g., citric acid) ; additional surfactants; antibacterial agents, fragrances; and thickeners.
  • pH adjusting agents e.g., citric acid
  • additional surfactants e.g., sodium EDTA
  • antibacterial agents e.g., sodium EDTA
  • fragrances e.g., sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite
  • the composition according to the present invention comprises a pH adjusting agent, so that the composition has a pH value of from 4.0 to 7.5, preferably from 4.5 to 7.0, more preferably from 5.0 to 6.5.
  • a person skilled in the art can adjust the type and amount of additional ingredients present in the compositions according to the present invention by means of routine operations, so that the desired properties of these compositions are not adversely affected by the additional ingredients.
  • the present invention relates to a composition, preferably for cleansing and/or removing makeups from keratin materials, comprising, relative to the total weight of the composition:
  • At least one amino acid surfactant selected from sodium lauroyl sarcosinate, sodium cocoyl glycinate, sodium lauroyl glutamate, sodium cocoyl glutamate, sodium stearoyl glycinate, sodium stearoyl glutamate, disodium cocoyl glycinate, disodium cocoyl glutamate, potassium cocoyl glycinate, TEA-cocoyl glutamate, and a mixture thereof; and
  • n designates an integer ranging from 9 to 27, preferably from 9 to 21, more preferably from 11 to 17;
  • m designates an integer varying from 1 to 50, preferably from 1 to 25, more preferably from 1 to 10, even more preferably from 1 to 8, most preferably from 1 to 6,
  • M and M' designate, independently of each other, a hydrogen atom, an alkali metal or alkali earth metal, an ammonium group or a cation derived from an amine.
  • composition according to the present invention can be used in a process for cleansing and/or removing makeups from keratin materials, such as the skin, in particular the face, by being applied to the keratin materials.
  • composition according to the present invention has a good foaming volume during application.
  • composition according to the present invention further provides a good skin sensory (i.e., a moisturized and smooth skin feeling) after application.
  • a good skin sensory i.e., a moisturized and smooth skin feeling
  • the composition according to the present invention can provide a quick rinse-off speed.
  • the composition according to the present invention has no dripping issue.
  • dripping issue it means that the viscosity of the composition is lower than 1000 mPa. s, it will be considered to have a dripping issue.
  • composition according to the invention may be applied by any means enabling a uniform distribution, in particular using a finger, or a cotton ball, and can be removed by rinsing with water.
  • the present invention provides a non-therapeutic process for cleansing and/or removing makeups from keratin materials, in particular the skin, comprising application to the keratin materials, in particular the skin, of the composition according to the present invention, and rinsing off said composition after an optional period of time.
  • composition of invention examples (IE. ) 1-2 and comparative examples (CE. ) 1-4 were prepared with the components listed in Table 2 (the contents were expressed as weight percentages of active materials relative to the total weight of each composition) :
  • composition of invention example 1 and 2 represent the composition of the present invention.
  • Composition of comparative example 1 does not comprise at least one glycolipid.
  • Composition of comparative example 2 does not comprise at least one amino acid surfactant.
  • Composition of comparative example 3 does not comprises at least one (poly) oxyalkylenated C10-C28 fatty alcohol sulfosuccinate.
  • Composition of comparative example 4 does not comprise at least 2 wt. %of at least one amino acid surfactant, relative to the total weight of the composition.
  • compositions were prepared as follows.
  • compositions obtained were evaluated by 10 trained volunteers in terms of foam volume, skin sensory, in particular, skin smoothness, and rinse-off speed as follows.
  • composition according to the present invention can result in big foam volume and deliver a very moisturized and smooth sensation on the skin, and can even have a quick rinse-off speed.
  • the viscosity of each composition was measured at 25°C, using a Rheomat R180 viscometer equipped with a spindle M4, the measurement being performed after 10 minutes of rotation of the spindle in a sample (after which time stabilization of the viscosity and of the spin speed of the spindle are observed) , at a shear rate of 200 rpm.
  • the viscosity for each composition was summarized in Table 6
  • composition according to the present invention has a viscosity higher than 1000 mPa.s, and has no dripping issue.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition, de préférence pour le nettoyage et/ou le démaquillage de matières kératiniques, comprenant : (i) au moins un glycolipide ; (ii) au moins 2% en poids d'au moins un tensioactif d'acide aminé, rapportés au poids total de la composition ; et (iii) au moins un sulfosuccinate d'alcool gras en C10-C28 (poly)oxyalkyléné. Elle concerne également un procédé non thérapeutique de nettoyage et de démaquillage de matières kératiniques, en particulier de la peau, comprenant l'application sur les matières kératiniques, en particulier sur la peau, de ladite composition, et le rinçage de ladite composition après un éventuelle intervalle de temps.
PCT/CN2024/089308 2024-04-23 2024-04-23 Composition pour le nettoyage et/ou le démaquillage de matières kératiniques Pending WO2025222373A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2024/089308 WO2025222373A1 (fr) 2024-04-23 2024-04-23 Composition pour le nettoyage et/ou le démaquillage de matières kératiniques
FR2405387A FR3161358A3 (fr) 2024-04-23 2024-05-27 Composition de nettoyage et/ou de démaquillage de matières kératineuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2024/089308 WO2025222373A1 (fr) 2024-04-23 2024-04-23 Composition pour le nettoyage et/ou le démaquillage de matières kératiniques

Publications (1)

Publication Number Publication Date
WO2025222373A1 true WO2025222373A1 (fr) 2025-10-30

Family

ID=97404722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2024/089308 Pending WO2025222373A1 (fr) 2024-04-23 2024-04-23 Composition pour le nettoyage et/ou le démaquillage de matières kératiniques

Country Status (2)

Country Link
FR (1) FR3161358A3 (fr)
WO (1) WO2025222373A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130040869A1 (en) * 2010-03-31 2013-02-14 Trevor Frederick Cox Mild to the skin, foaming detergent composition
US20140349902A1 (en) * 2011-12-28 2014-11-27 Evonik Industries Ag Aqueous hair and skin cleaning compositions comprising biosurfactants
US20180023040A1 (en) * 2015-03-18 2018-01-25 Evonik Degussa Gmbh Composition containing peptidase and biosurfactant
CN111000766A (zh) * 2019-12-16 2020-04-14 佛山市奥姿美生物科技有限公司 氨基酸洁面膏及其制备方法
WO2023016943A1 (fr) * 2021-08-09 2023-02-16 Croda International Plc Composition
US20230270644A1 (en) * 2020-09-23 2023-08-31 L'oreal Composition for cleansing and/or removing makeups from keratin materials
CN117137817A (zh) * 2023-08-25 2023-12-01 上海炫美生物科技有限公司 一种去残留组合物、敏感肌氨基酸洗面奶及其制备方法
WO2023247575A1 (fr) * 2022-06-20 2023-12-28 L'oreal Composition comprenant au moins un glycolipide, au moins un alcool gras liquide linéaire ou ramifié, au moins une huile non siliconée et au moins un tensioactif, utilisation et procédé utilisant la composition
CN117838565A (zh) * 2024-01-10 2024-04-09 诺斯贝尔化妆品股份有限公司 一种洁面卸妆啫喱及其制备方法

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130040869A1 (en) * 2010-03-31 2013-02-14 Trevor Frederick Cox Mild to the skin, foaming detergent composition
US20140349902A1 (en) * 2011-12-28 2014-11-27 Evonik Industries Ag Aqueous hair and skin cleaning compositions comprising biosurfactants
US20180023040A1 (en) * 2015-03-18 2018-01-25 Evonik Degussa Gmbh Composition containing peptidase and biosurfactant
CN111000766A (zh) * 2019-12-16 2020-04-14 佛山市奥姿美生物科技有限公司 氨基酸洁面膏及其制备方法
US20230270644A1 (en) * 2020-09-23 2023-08-31 L'oreal Composition for cleansing and/or removing makeups from keratin materials
WO2023016943A1 (fr) * 2021-08-09 2023-02-16 Croda International Plc Composition
WO2023247575A1 (fr) * 2022-06-20 2023-12-28 L'oreal Composition comprenant au moins un glycolipide, au moins un alcool gras liquide linéaire ou ramifié, au moins une huile non siliconée et au moins un tensioactif, utilisation et procédé utilisant la composition
CN117137817A (zh) * 2023-08-25 2023-12-01 上海炫美生物科技有限公司 一种去残留组合物、敏感肌氨基酸洗面奶及其制备方法
CN117838565A (zh) * 2024-01-10 2024-04-09 诺斯贝尔化妆品股份有限公司 一种洁面卸妆啫喱及其制备方法

Also Published As

Publication number Publication date
FR3161358A3 (fr) 2025-10-24

Similar Documents

Publication Publication Date Title
EP3324926B1 (fr) Composition pour nettoyer un matériau kératinique contenant un tensioactif d'acide aminé
JP4644493B2 (ja) 界面活性剤組成物ならびにそれを用いた洗浄剤組成物および乳化組成物
US5734029A (en) Preparation of improved alkypolygloycoside surfactant mixtures
US5449763A (en) Preparation of alkylpolyglycosides
WO2004092315A1 (fr) Composition d'agent de nettoyage
ES2254823T3 (es) Concentrados acuosos de brillo perlado.
JP7156083B2 (ja) 皮膚用洗浄剤組成物
WO2006030881A1 (fr) Composition detergente
JPWO2005078039A1 (ja) 増粘組成物
JP7660083B2 (ja) アミノ酸系界面活性剤を含むクレンジングフォーム化粧料組成物
US20240374496A1 (en) Composition for caring for keratin materials
JPH0853693A (ja) 洗浄剤組成物
WO2025222373A1 (fr) Composition pour le nettoyage et/ou le démaquillage de matières kératiniques
CN113873988B (zh) 用于清洁角蛋白材料的组合物
WO2025222366A1 (fr) Composition de nettoyage et/ou de démaquillage de matières kératiniques
JP2024000268A (ja) 糖脂質及びクエン酸誘導体を含む組成物
JP2005146014A (ja) 低温安定性の改善されたアルキルグリコール多価アルコールエーテル含有界面活性剤組成物、及びこれを含有する洗浄剤組成物
KR101062626B1 (ko) 세정제 조성물
WO2025222372A1 (fr) Composition pour le nettoyage et/ou le démaquillage de matières kératiniques
CN119497607A (zh) 包含糖脂、牛磺酸盐表面活性剂和氨基酸表面活性剂的组合物
JP4704056B2 (ja) 皮膚洗浄剤組成物
WO2025163661A1 (fr) Composition de gel pour le nettoyage de matière kératinique et procédés associés
CN115298296A (zh) 通过使用糖类同分异构体提高洗涤剂组合物的发泡特性的方法
JP2023149358A (ja) 皮膚洗浄用組成物
JP2025001457A (ja) 低分子量キトサン及び糖脂質を含む組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24936291

Country of ref document: EP

Kind code of ref document: A1